A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Geographic Atrophy, Macular Degeneration

In brief

This study will assess the safety and efficacy of the brimonidine intravitreal implant in participants with geographic atrophy due to age-related macular degeneration.

Key facts

Study ID
NCT02087085
Run by
Allergan
People needed
310
Starts
2014-05-09
Expected to finish
2018-03-30
Last updated by the study team
2019-04-23

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.